In vitro pharmacokinetics and pharmacodynamics of the diarylquinoline TBAJ-587 and its metabolites against Mycobacterium tuberculosis
Diana A. Aguilar-Ayala, Marie Sylvianne Rabodoarivelo, Maxime Eveque, Albin A. M. Leding, Lindsay Sonnenkalb, Ana Picó, Nicolas Willand, Natalya V. Serbina, Ulrika S. H. Simonsson, Ainhoa Lucía, Santiago Ramón‐García
This study evaluates the in vitro pharmacokinetics and pharmacodynamics of TBAJ-587 and its metabolites against M. tuberculosis, showing their efficacy and binding behavior in different media.
Frontiers in Microbiology · Jun 29, 2026Peer-reviewedPharmacology & Toxicology